 Mark Krueger |
Mark Krueger, who ran his own healthcare constitutency relations consulting firm for 23 years before selling it in 2018, has joined APCO Worldwide as executive director in its New York office.
Working for biotech, pharmaceutical, medical device and diagnostics clients, Mark Krueger & Assocs. is noted for creating/implementing ways to speed drug discovery, quicken regulatiory approval and demonstrate its value to lead to appropriate pricing, access and reimbursement.
Brad Staples, APCO CEO, praised Krueger as a "trusted partner" to patient, consumer groups, NGOs and professional societies. "Mark has a proven track record of creating respectful partnerships focused on interests shared between these groups, industry, government and other members of the community,” he said.
Alexandra Lazorchak leads APCO's North American health practice and co-chairs the global health unit with James Tyrrell.
Jim Weiss, founder & chairman of Real Chemistry, has joined the board of ICR Inc. as it steps up its healthcare capital markets offering.
Ruder Finn has hired Kelly Yoder, who spent a dozen years at Weber Shandwick rising to North America health lead, as managing director, global head of health & life sciences.
ICR has named John Capodanno head of US healthcare corporate communications and Matthew Willey managing director in its medical technology and diagnostics practice. 
April is National Minority Health Month, spotlighting the urgency to improve health outcomes in communities of color.
In a recent conversation about the evolving media landscape, Doug Simon, CEO of D S Simon Media, spoke with Campbell O’Connor, Group Director, Media & Engagement at Real Chemistry, about how AI is influencing media relations and healthcare communications.
